Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Spliceosome mutations are common in persons with myeloproliferative neoplasm-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide

Detaylı Bibliyografya
Asıl Yazarlar:	Chowdhury, O, O’Sullivan, J, Barkas, N, Wang, G, Buck, G, Hamblin, A
Materyal Türü:	Journal article
Dil:	English
Baskı/Yayın Bilgisi:	Springer Nature 2020

Benzer Materyaller

Spliceosome mutations are common in MPN-associated myelofibrosis with RBC-transfusion-dependence and correlate with response to pomalidomide
Yazar:: Chowdhury, O, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Non-driver mutations in myeloproliferative neoplasm-associated myelofibrosis
Yazar:: Bing Li, ve diğerleri
Baskı/Yayın Bilgisi: (2017-05-01)

Mechanisms of disease transformation in myeloproliferative neoplasms
Yazar:: O'Sullivan, J
Baskı/Yayın Bilgisi: (2022)

Heterogeneity in myeloproliferative neoplasms: causes and consequences
Yazar:: O'Sullivan, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Profile of pomalidomide and its potential in the treatment of myelofibrosis
Yazar:: Gowin KL, ve diğerleri
Baskı/Yayın Bilgisi: (2015-04-01)

The UK Myeloproliferative Neoplasm Registry for Myelofibrosis (UK-MPN-MF registry)
Yazar:: Butt, N, ve diğerleri
Baskı/Yayın Bilgisi: (2019)

Somatic mutations of calreticulin in myeloproliferative neoplasms and myelodysplastic/myeloproliferative neoplasms
Yazar:: Luca Malcovati, ve diğerleri
Baskı/Yayın Bilgisi: (2014-11-01)

Thrombosis in myeloproliferative neoplasms: a viewpoint on its impact on myelofibrosis, mortality, and solid tumors
Yazar:: Tiziano Barbui, ve diğerleri
Baskı/Yayın Bilgisi: (2024-10-01)

TGF-β signaling in myeloproliferative neoplasms contributes to myelofibrosis without disrupting the hematopoietic niche
Yazar:: Juo-Chin Yao, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Single-cell methods in myeloproliferative neoplasms: old questions, new technologies
Yazar:: O'Sullivan, JM, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

Benefits and pitfalls of pegylated interferon-α2a therapy in patients with myeloproliferative neoplasm-associated myelofibrosis: a French Intergroup of Myeloproliferative neoplasms (FIM) study
Yazar:: Jean-Christophe Ianotto, ve diğerleri
Baskı/Yayın Bilgisi: (2018-03-01)

Ph-negative chronic myeloproliferative neoplasm (primary myelofibrosis)– as one of the reasons of the Budd-Chiari syndrome.
Yazar:: Maria Dmitrievna Sanatko
Baskı/Yayın Bilgisi: (2012-06-01)

Ph-negative chronic myeloproliferative neoplasm (primary myelofibrosis)– as one of the reasons of the Budd-Chiari syndrome.
Yazar:: Maria Dmitrievna Sanatko
Baskı/Yayın Bilgisi: (2012-01-01)

Mutations in the miR-142 gene are not common in myeloproliferative neoplasms
Yazar:: Paulina Galka-Marciniak, ve diğerleri
Baskı/Yayın Bilgisi: (2022-06-01)

Evaluation of Common Genetic Disorders in Myeloproliferative Neoplasms
Yazar:: Mehrdad Payandeh, ve diğerleri
Baskı/Yayın Bilgisi: (2011-09-01)

Evaluation of Common Genetic Disorders in Myeloproliferative Neoplasms
Yazar:: Hoshang Yousefi, ve diğerleri
Baskı/Yayın Bilgisi: (2011-10-01)

CALR Mutations in Myeloproliferative Neoplasms
Yazar:: Ken-Hong Lim
Baskı/Yayın Bilgisi: (2014-06-01)

Myelodysplastic syndrome/myeloproliferative neoplasm – ring sideroblast with myelofibrosis – A diagnostic dilemma/? A distinct entity
Yazar:: Amandeep Talwar, ve diğerleri
Baskı/Yayın Bilgisi: (2021-01-01)

Myeloproliferative neoplasms
Yazar:: Nick Cross, (Coordinating Author)
Baskı/Yayın Bilgisi: (2019-06-01)

Myeloproliferative neoplasms
Yazar:: Jean-Jacques Kiladjian
Baskı/Yayın Bilgisi: (2018-06-01)

A Case of Philadelphia Chromosome Positive Myeloproliferative Neoplasm in a Pregnant Woman with Unusual Primary Myelofibrosis Features
Yazar:: Jason Koshy, ve diğerleri
Baskı/Yayın Bilgisi: (2013-01-01)

Epigenetics and mutations in chronic myeloproliferative neoplasms
Yazar:: Alessandro M. Vannucchi, ve diğerleri
Baskı/Yayın Bilgisi: (2011-10-01)

Functional Consequences of Mutations in Myeloproliferative Neoplasms
Yazar:: Stefan N. Constantinescu, ve diğerleri
Baskı/Yayın Bilgisi: (2021-06-01)

Mutations, inflammation and phenotype of myeloproliferative neoplasms
Yazar:: Sylvie Hermouet, ve diğerleri
Baskı/Yayın Bilgisi: (2023-05-01)

RAS-pathway mutations are common in patients with ruxolitinib refractory/intolerant myelofibrosis: molecular analysis of the PAC203 cohort
Yazar:: O'Sullivan, JM, ve diğerleri
Baskı/Yayın Bilgisi: (2023)

The microenvironment in myeloproliferative neoplasm
Yazar:: Simón Méndez-Ferrer, ve diğerleri
Baskı/Yayın Bilgisi: (2018-06-01)

Spleen in myeloproliferative neoplasms
Yazar:: Giovanni Barosi
Baskı/Yayın Bilgisi: (2018-06-01)

Epigenetics in myeloproliferative neoplasms
Yazar:: Graeme Greenfield, ve diğerleri
Baskı/Yayın Bilgisi: (2023-07-01)

Treatment of Myeloproliferative Neoplasms With Janus Kinase Inhibitors: A Meta‐Analysis of Cardiovascular Safety
Yazar:: Roberta Dunn, ve diğerleri
Baskı/Yayın Bilgisi: (2025-02-01)

Myelodysplastic/Myeloproliferative Neoplasms with Features Intermediate between Primary Myelofibrosis and Chronic Myelomonocytic Leukemia: Case Series and Review of the Entity
Yazar:: Arturo Bonometti, ve diğerleri
Baskı/Yayın Bilgisi: (2024-07-01)

JAK1 somatic mutation in a myeloproliferative neoplasm
Yazar:: Suzanne O. Arulogun, ve diğerleri
Baskı/Yayın Bilgisi: (2017-08-01)

Comparison and Implications of Mutational Profiles of Myelodysplastic Syndromes, Myeloproliferative Neoplasms, and Myelodysplastic/Myeloproliferative Neoplasms: A Meta-Analysis
Yazar:: Ziqi Wan, ve diğerleri
Baskı/Yayın Bilgisi: (2020-10-01)

Impact of mutations on pregnancy outcome in patients with myeloproliferative neoplasms
Yazar:: Dawn Maze, ve diğerleri
Baskı/Yayın Bilgisi: (2023-02-01)

Transcription factor mutations in myelodysplastic/myeloproliferative neoplasms
Yazar:: Thomas Ernst, ve diğerleri
Baskı/Yayın Bilgisi: (2010-09-01)

FREQUENCY OF CALR GENE MUTATION IN MYELOPROLIFERATIVE NEOPLASMS
Yazar:: Sana Latif, ve diğerleri
Baskı/Yayın Bilgisi: (2020-04-01)

Classification and personalized prognosis in myeloproliferative neoplasms
Yazar:: Grinfeld, J, ve diğerleri
Baskı/Yayın Bilgisi: (2018)

Inhibition of interleukin-1β reduces myelofibrosis and osteosclerosis in mice with JAK2-V617F driven myeloproliferative neoplasm
Yazar:: Shivam Rai, ve diğerleri
Baskı/Yayın Bilgisi: (2022-09-01)

Myeloproliferative neoplasm stem cells
Yazar:: Mead, A, ve diğerleri
Baskı/Yayın Bilgisi: (2017)

The Hematopoietic Niche in Myeloproliferative Neoplasms
Yazar:: Annette H. Schmitt-Graeff, ve diğerleri
Baskı/Yayın Bilgisi: (2015-01-01)

Pathophysiology of thrombosis in myeloproliferative neoplasms
Yazar:: Raffaele Landolfi, ve diğerleri
Baskı/Yayın Bilgisi: (2011-02-01)